##plugins.themes.academic_pro.article.sidebar##

Download
pdf
Statistic
Read Counter : 89 Download : 46

##plugins.themes.academic_pro.article.main##

Abstract

Studying of the corrective effect of longitudinal gastrectomy on concomitant diseases in patients with morbid obesity. This scientific work is based on the results of a comprehensive examination and treatment of 187 patients with MO who were treated in the our clinical bases from 2021 to 2023. The analysis of comorbidities in the compared groups showed that one or more comorbidities were detected in 72% of the control group, 77% of the main group. The main part of these patients was made up of patients with obesity of the III degree. The proposed modification of SG in morbidly obese patients improved the cardioesophageal function and the strength of the gastroduodenal staple line, eliminating the observed complication of staple line failure of 2.2%. It also led to a decrease in the symptoms of gastroesophageal reflux disease from 14% to 6.1%. In the longitudinal gastric resection procedure, the use of local hemostatic powder "HEMOBEN" along the gastric staple line reduced the bleeding complication from 3.2% to 1.1% and the duration of the procedure by an average of 15±3 minutes.In particular, if in the control and main groups, arterial hypertension was detected in 50 and 59.3% of patients before the surgical procedure, then 3 months after the surgical procedure, an increase in blood pressure was observed in 45.4 and 37% of the patients. After surgery, the clinical signs of arterial hypertension and arthralgia in patients with morbid obesity gradually disappeared with the elimination of obesity. In conclusion, these clinical signs were caused by obesity, and its elimination led to the disappearance of these clinical signs.

Keywords

morbid obesity bariatric surgery concomitant diseases

##plugins.themes.academic_pro.article.details##

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

How to Cite
A.S. Murodov, O.R.Teshaev, & A.R.Mavlyanov. (2024). Evaluating The Effectiveness Of Laparoscopic Longitudinal Gastric Resection Surgery On Early Postoperative Complications And Obesity-Related Comorbidities. Texas Journal of Medical Science, 39, 16–25. Retrieved from https://zienjournals.com/index.php/tjms/article/view/5773

References

  1. Afshin A., Forouzanfar M.H., Reitsma M.B., Sur P., Estep K., Lee A. et al. Health Effects of
  2. Overweight and Obesity in 195 Countries over 25 Years. N Engl J Med 2017;377: 13-27.
  3. Balint I.B., Orban L., Farics A., Manfai G., Radics P. (2019) Laparoscopic gastric plication with
  4. pylorus preserving duodenoileal bypass for treating morbid obesity. Orv Hetil 160(43):1714–1718
  5. Carrano FM, Peev MP, Saunders JK, Melis M, Tognoni V, Di Lorenzo N (2020) The role of
  6. minimally invasive and endoscopic technologies in morbid obesity treatment: review and critical
  7. appraisal of the current clinical practice. Obes Surg 30(2):736– 752. https://doi.org/10.1007/s11695-
  8. -04302-8.
  9. Colquitt JL, Pickett K, Loveman E, Frampton GK. Surgery for weight loss in adults. Cochrane
  10. Database of Systematic Reviews 2014, Issue 8. Art. No.: CD003641. https://doi.org/10.1002/14651
  11. Cresci B, Cosentino C, Monami M, Mannucci E. Metabolic surgery for the treatment of type 2
  12. diabetes: a network metaanalysis of randomized controlled trials. Diabetes Obes Metab. 2020 Apr 3.
  13. https://doi.org/10.1111/dom.14045.
  14. Ding L., Fan Y., Li H., Zhang Y., Qi D., Tang S., Cui J., He Q., Zhuo C., Liu M. (2020)
  15. Comparative efectiveness of bariatric surgeries in patients with obesity and type 2 diabetes mellitus:
  16. a network metaanalysis of randomized controlled trials. Obes Rev 21(8):e13030.
  17. https://doi.org/10.1111/obr.13030.
  18. English W. J., DeMaria E. J., Brethauer S. A., Mattar S. G., Rosenthal R. J., and Morton J. M.,
  19. “American society for metabolic and bariatric surgery estimation of metabolic and bariatric
  20. procedures performed in the United States in 2016,” Surgery for Obesity and Related Diseases, vol.
  21. , no. 3, pp. 259–263, 2018.
  22. Freedman DM, Ron E, Ballard-Barbash R, et al. Body mass index and all-cause mortality in a
  23. nationwide US cohort. Int. J. Obes. 2006;30(5):822-829. doi: 10.1038/sj.ijo.0803193.
  24. Guh DP, Zhang W, Bansback N, et al. The incidence of co-morbidities related to obesity and
  25. overweight: A systematic review and meta-analysis. BMC Public Health. 2009;9(1). doi:
  26. 1186/1471-2458-9-88.
  27. Jossart G. H., “,e history of sleeve gastrectomy,” Bariatric Times, vol. 7, no. 2, pp. 9-10, 2010.
  28. Jungheim ES, Travieso JL, Carson KR, Moley KH. Obesity and reproductive function. Obstetrics
  29. and gynecology clinics of North America. 2012; 39 (4): 479-93. DOI: 10.1016/j.ogc.2012.09.002.
  30. Lee C. M., Cirangle P. T., and Jossart G. H., “Vertical gastrectomy for morbid obesity in 216
  31. patients: report of two year results,” Surgical Endoscopy, vol. 21, no. 10, pp. 1810–1816, 2007.
  32. Lenz M, Richter T, Muhlhauser I. The morbidity and mortality associated with overweight and
  33. obesity in adulthood: a systematic review. Dtsch Arztebl Int. 2009;106(40):641-648. doi:
  34. 3238/arztebl.2009.0641.
  35. Li L., Yu H., Liang J. et al., “Meta-analysis of the effectiveness of laparoscopic adjustable gastric
  36. banding versus laparoscopic sleeve gastrectomy for obesity,” Medicine (Baltimore), vol. 98, no. 9,
  37. Article ID e14735, 2019 Mar.
  38. Lopez, P.P. Outpatient complications encountered following Roux-en- Y gastric bypass / P.P. Lopez,
  39. N.A. Patel, L.S. Koche // Med Clin North Am. -2007-Vol. 91, N 3. — Р. 471-483.
  40. Naslund E, Granstrom L, Stockeld D, Backman L. Marlex Mesh Gastric Banding: A 7-12 Year
  41. Follow-up. Obes Surg. 1994;4(3):269-273. doi: 10.1381/096089294 765558494.
  42. Nazirov F. G. Khaybullina Z. R., Khashimov Sh.t Kh., Sharapov N. U., Makhmudov U. M.
  43. Abdullaeva S.D.Cardiometabolic risk reduction after laparoscopic sleeve gasterectomy. Journal of
  44. cardiorespiratory research. 2020, vol. 1, issue 1, pp.54-58
  45. Obesity prevalence from a European perspective: a systematic review / A. Berghöfer, T. Pischon, T.
  46. Reinhold [et al.] // BMC Public Health. – 2008. –Vol. 8, № 200. – P. 1-10
  47. Palermo M. and Serra E., “Laparoscopic sleeve gastrectomy: how do I do it,” Journal of
  48. Laparoendoscopic & Advanced Surgical Techniques, vol. 30, no. 1, pp. 2–5, 2020.
  49. Ponc J. e, DeMaria E. J., Nguyen N. T., Hutter M., Sudan R. and Morton J. M., “American society
  50. for metabolic and bariatric surgery estimation of bariatric surgery procedures in 2015 and surgeon
  51. workforce in the United States,” Surgery for Obesity and Related Diseases, vol. 12, no. 9, pp. 1637–
  52. , 2016.
  53. Trends in Obesity and Severe Obesity Prevalence in US Youth and Adults by Sex and Age, 2007-
  54. to 2015-2016 / C.M. Hales, C.D. Fryar, M.D. Carroll [et al.] // JAMA. – 2018. – Vol. 319, №
  55. – P. 1723-1725.